Chemotherapy within 30 days prior to liver resection does not increase postoperative morbidity or mortality

HPB

Volumn 11, Issue 8, 2009, Pages 645-655

  Fahy, Bridget N ^a   Aloia, Thomas A ^a   Jones, Stephen L ^a   Bass, Barbara L ^a   Fischer, Craig P ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Chemotherapy; Liver resection; Morbidity; Mortality

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CANCER RECURRENCE; COMORBIDITY; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HUMAN; LIVER CANCER; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT SAFETY; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE CARE; PREOPERATIVE TREATMENT; RISK ASSESSMENT; RISK REDUCTION; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

EID: 73449101431     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00107.x     Document Type: Article

References (28)

1. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK et al. (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698-708; discussion 708-710.
2. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al. (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766.
3. McColl RJ, You X, Ghali WA, Kaplan G, Myers R, Dixon E. (2008) Recent trends of hepatic resection in Canada: 1995-2004. J Gastrointest Surg. 12:1839-1846; discussion 1846.
4. Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082-1088.
5. Scoggins CR, Campbell ML, Landry CS, Slomiany BA, Woodall CE, McMasters KM et al. (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16:35-41.
6. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B et al. (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1-7.
7. Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giacchetti S et al. (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 24:4983-4990.
8. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M et al. (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460-466.
9. Sahajpal A, Vollmer CM Jr, Dixon E, Chan EK, Wei A, Cattral MS et al. (2007) Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect perioperative outcomes. J Surg Oncol 95:22-27.
10. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072.
11. Konopke R, Kersting S, Bunk A, Dietrich J, Denz A, Gastmeier J et al. (2009) Colorectal liver metastasis surgery: analysis of risk factors predicting postoperative complications in relation to the extent of resection. Int J Colorectal Dis 24:687-697.
12. Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB et al. (1998) The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled programme for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg 228:491-507.
13. Khuri SF, Daley J, Henderson W, Hur K, Gibbs JO, Barbour G et al. (1997) Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 185:315-327.
14. Daley J, Khuri SF, Henderson W, Hur K, Gibbs JO, Barbour G et al. (1997) Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 185:328-340.
15. Khuri SF. (2005) The NSQIP: a new frontier in surgery. Surgery 138:837-843.
16. Fink AS, Campbell DA Jr, Mentzer RM Jr, Henderson WG, Daley J, Bannister J et al. (2002) The National Surgical Quality Improvement Program in non-veterans administration hospitals: initial demonstration of feasibility. Ann Surg 236:344-353; discussion 353-354.
17. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318; discussion 318-321.
18. Welsh FK, Tilney HS, Tekkis PP, John TG, Rees M (2007) Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 96:1037-1042.
19. Hewes JC, Dighe S, Morris RW, Hutchins RR, Bhattacharya S, Davidson BR (2007) Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg 31:353-364; discussion 365-366.
20. Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL, Henderson WG et al. (2007) Morbidity and mortality after liver resection: results of the Patient Safety in Surgery Study. J Am Coll Surg 204:1284-1292.
21. Melis M, McLoughlin JM, Michelle Dean E, Siegel EM, Weber JM, Shah N et al. (2009) Correlations between neoadjuvant treatment, anaemia, and perioperative complications in patients undergoing oesophagectomy for cancer. J Surg Res 153:114-120.
22. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al. (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236:397-406; discussion 406-407.
23. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38-46.
24. Harpole DH Jr, DeCamp MM Jr, Daley J, Hur K, Oprian CA, Henderson WG et al. (1999) Prognostic models of 30-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg 117:969-979.
25. Verwaal VJ, Wobbes T, Koopman-van Gemert AW, Buskens FG, Theeuwes AG. (1992) Effect of perioperative blood transfusion and cell saver on the incidence of postoperative infective complications in patients with an aneurysm of the abdominal aorta. Eur J Surg 158:477-480.
26. Torchia MG, Danzinger RG (2000) Perioperative blood transfusion and albumin administration are independent risk factors for the development of postoperative infections after colorectal surgery. Can J Surg 43:212-216.
27. Fong Y, Brennan MF, Cohen AM, Heffernan N, Freiman A, Blumgart LH (1997) Liver resection in the elderly. Br J Surg 84:1386-1390.
28. Clavien PA, Camargo CA Jr, Croxford R, Langer B, Levy GA, Greig PD. (1994) Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg 220:109-120.